RA
BSX icon

Resolute Advisors’s Boston Scientific BSX Stock Holding History

Resolute Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-635
Closed -$28K – 233
2021
Q3 		$28K Hold
635
– – ﹤0.01% 185
2021
Q2 		$27K Hold
635
– – ﹤0.01% 144
2021
Q1 		$25K Buy
+635
New +$24K ﹤0.01% 122

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Resolute Advisors's BSX Position: Q4 2021 in Review

Resolute Advisors sold out of Boston Scientific (BSX) in Q4 2021, closing a stake of 635 shares — an estimated $28K sold.

Resolute Advisors first reported a position in BSX in Q1 2021 and held it in 3 quarters. The position peaked at $28K in Q3 2021. 888 funds tracked by Wall St. Rank hold BSX as of Q4 2021.

  • Resolute Advisors reported no remaining Boston Scientific position as of Q4 2021 after selling out during the quarter.
  • Resolute Advisors sold 635 Boston Scientific shares in Q4 2021, an estimated $28K.
  • Resolute Advisors first reported a position in Boston Scientific in Q1 2021 and held it in 3 quarters.
  • Resolute Advisors's Boston Scientific position peaked at $28K in Q3 2021.
  • 888 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.